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Viral fusion proteins are attached to the membrane of enveloped viruses (a group that
includes Coronaviruses, Dengue, HIV and Influenza) and catalyze fusion between the viral
and host membranes, enabling the virus to insert its genetic material into the host cell.
Given the importance of these biomolecules, this work presents a centralized database
containing the most relevant information on viral fusion proteins, available through a
free-to-use web server accessible through the URL https://viralfp.bio.di.uminho.pt/. This
web application contains several bioinformatic tools, such as Clustal sequence alignment
and Weblogo, including as well a machine learning-based tool capable of predicting
the location of fusion peptides (the component of fusion proteins that inserts into the
host’s cell membrane) within the fusion protein sequence. Given the crucial role of these
proteins in viral infection, their importance as natural targets of our immune system and
their potential as therapeutic targets, this web application aims to foster our ability to fight
pathogenic viruses.
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1. INTRODUCTION
Enveloped viruses, a group of viruses that includes SARS-CoV-2, Dengue, Influenza and HIV, are
characterized by having an exterior lipid envelope that contains at least one type of glycoprotein on
its surface (1, Preface I) (2, 3). These proteins play an essential role during the virus entry into the
host cell, enabling the binding of the virus to receptors on the host cell and catalyzing the fusion
between the viral envelope and the host cell membrane.
In some viruses, a single protein can induce the binding to the host receptor and catalyze the
fusion reaction, whereas other viruses requiremultiple proteins for these tasks. Viral fusion proteins
(VFP) are key players in a process called membrane fusion, through which the virus inserts its
genetic material into the host cell, enabling it to replicate (4, 5).
During membrane fusion, the viral envelope and the host cellular membrane are brought into
close contact in order to merge into a single membrane (6, 7). According to the most widely
accepted membrane fusion model, this process is initiated when the VFP binds to the host
receptor. Triggered by an external stimulus, the protein becomes extended and inserts its fusion
peptide (FPep) into the host membrane. The VFP folds back, which leads to the approximation
of the two membranes. After this step, the mechanism passes through a hemifusion intermediate,
which encompasses the fusion of the outer leflets of the membranes without the contact of the
inner leaflets. This hemifused step forms a stalk-like structure, diminishing the contact area to
a minimum, lowering the free energy barrier required to overcome hydration repulsion. Finally,
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fusion of the unattached inner leaflets occurs, which starts to
form a hydrophilic pore that will eventually enlarge, connecting
the 2 initially separated intermembrane volumes (4, 5, 8–10).
VFPs can assume multiple possible forms depending on their
corresponding virus. Currently, the consensus is that VFPs can
be grouped into 3 classes: I, II, and III, each with their own
characteristics, such as their prefusion, pre-hairpin and post-
fusion structures, orientation within virus membrane, types of
possible triggering mechanisms and location of their FPep (4, 5,
7, 11).
The FPep is a conserved sequence within VFPs of the
same viral family that can insert into the host membrane,
allowing the fusion of the viral envelope with the host
cell membrane. This peptide can promote the reaction of
fusion of membrane vesicles by itself, even if it is detached
from the rest of the VFP (4, 11). All FPeps share common
characteristics, which are determinant for their function: they
are hydrophobic, rich in Gly and Ala residues, contain aromatic
residues and are usually conserved within a species (mutations
frequently lead to a loss of function) (4, 11). Apart from
these general characteristics, FPeps from virus belonging to
different families can be quite diverse (4). Some FPeps (e.g.,
Influenza and HIV) are located at the N-terminal tip of the
fusion protein, whereas the peptides of other viruses (e.g.,
Dengue and Ebola) are internal fusion loops (4). The peptides
from different families are also quite different at the sequence
level and structure levels. The influenza FP is helical in lipidic
environments (12, 13), whereas the HIV FP tends to adopt β-
sheet structures (14), although it can become helical depending
on membrane composition (15). Other FPeps, such as the
one from Dengue virus, which only has 14 residues, do not
have a defined secondary structure (16). It is not clear how
peptides with such distinct characteristics play a common role in
membrane fusion.
The relevance of VFP and their FPep for membrane fusion
highlights them as potential therapeutic targets (4, 7). As an
example, the therapeutic application of VFPs as a target can be
found in the defining pandemic of 2020: COVID-19. Being an
enveloped virus, one of the key therapeutic targets of SARS-CoV-
2 is its VFP, the spike (S) protein (17). The most promising and
effective vaccines under development or already administrated
for this virus are based on the S protein’s mRNA. This group
of vaccines include the Moderna’s mRNA-1273 (18) and the
Pfizer-BioNTech’s BNT162b2 mRNA (19). In both, the mRNA
molecule is inserted into a lipid nanocarrier that stabilizes the
mRNA and delivers it into human cells. The mRNA once inside
a cell is translated to produce the S protein in its prefusion
conformation. The presence of those proteins in the human
cells induces an immune response on the organism, which will
produce antibodies that can target those proteins. For several
other enveloped viruses there are known antibodies that target
that region, like in cases of Dengue (20), Zika (21), HIV (22), and
Influenza (23).
Abbreviations: FPep, Fusion Peptide; ML, Machine Learning; VFP, Viral Fusion
Protein.
The known information for a given VFP can be found in
biological databases, like UniProt (24), NCBI Protein (25) and
PDB (26). However, a VFP oriented repository that contains
VFP related information does not exist, forcing researchers to
search several databases when they need to have comprehensive
characterization of one or several of these proteins.
To better understand how VFPs and their components
are characterized, some bioinformatics tools can be used, like
sequence alignment [e.g., BLAST (27), Clustal (28), and HMMER
(29)], that allow researchers to discover a protein’s conserved
residues, as well as other pieces of information regarding their
features. These analyses can provide valuable insights about how
VFPs operate.
Researchers have also been using machine learning (ML) to
study VFPs and their inhibitors. Several promising tools have
been developed using ML models trained using VFP and their
features, allowing the prediction of FPeps location within VFP
sequences (30, 31) and the prediction of inhibitors for different
VFPs to potentially be used in therapies of some diseases (32).
In this context, the main objective of the current work is
to develop a CRUD (Create, Read, Update and Delete) web
application, named ViralFP, that is capable of storing, retrieving,
displaying, and analysing the gathered data on enveloped
viruses [through information gathered from NCBI Taxonomy
(33) entries] and their VFPs, as well as to enable the data
navigation through a user-friendly interface. The web application
is freely available and aims to be useful for all elements of the
scientific community who are working with VFPs and FPeps.
The underlying data are stored in a relational database, which
contains relevant information regarding over 500 VFPs. Manual
curation of the database information was performed by reviewing
the original protein and taxonomy repositories’ data entries, as
well researching through scientific publications.The back-end
component of the application is built using Django and Django
REST API library, whilst its front-end is built using Angular
technology, a Typescript framework to build web applications.
This web application also includes a set of selected bioinformatics
tools, such as sequence alignment tools (like BLAST and Clustal)
andMLmodels capable to detect FPeps within the VFP sequence.
2. MATERIALS AND METHODS
The structure of the ViralFP application can be seen in the
Figure 1. There are three distinct components, each with its own
Docker container:
• The MySQL database-stores all the data that the server
requires.
• Django back-end, with Django REST framework–enables the
access and management of the database, besides containing
several data views that will be called by the front-end.
• Angular front-end-the application designed to be used by the
end user that displays the database information and allows the
execution of several tools.
In the next sections, a deeper explanation for each of those
components will be made.
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FIGURE 1 | Structure of the app: within the deployment server there are the 3 Docker containers: the MySQL, with the relational database; the Django (back-end) and
the Angular (front-end). The latter two can be accessed by a web client (e.g., browser or any application that a consumes RESTfull API).
2.1. Database
The VFP/FPep data present in the MySQL database was
retrieved from UniProt, NCBI Protein and PDB entries,
whilst the taxonomy information was originally from
NCBI Taxonomy. Its relational structure, names of the
tables and attributes, as well as the type of data stored
in each attribute can be seen on the scheme present
in Figure 2.
The core table of this database is called Protein and
contains the information regarding each VFP’s name, class, type
of activation, fusogenic peptide description (its name, location
within the protein and sequence), as well as having the UniProt
and NCBI Protein entries for the protein.
Another important table is the Fusion Peptide, which
describes the location of this peptide within the VFP sequence
(attribute Residues), sequence and some attributes regarding
annotation method and experimental evidence.
The last key table is the Taxonomy, which has all the relevant
taxonomy of the virus to which the protein belongs to (family,
genus, species, and subspecies/strain), as well as having the virus
NCBI Taxonomy entry.
Additional tables within the database include a table
with the possible structures of the VFP (through PDB
entries); a table for the virus’ hosts, which has the common
name and NCBI Taxonomy of each virus host organism;
an inhibitor/antibody table, that contains information
regarding those types of protein that are associated
with a particular VFP, and, finally, tables for additional
bibliographical references.
The data present in the database was manually curated by
verifying the original repositories of the data entries. Finally, the
inhibitors and antibodies entries for each VFP were filled using
BioPython (34) for the Pubmed automated searches, and pypdb
(35) for the PDB searches.
2.2. Back-End
The main purpose of the back-end is to enable the access to
the data from the MySQL database. This application component
converts data from SQL queries into JSON objects. Those objects
can be viewed and managed by a web client, which in this case
implements the front-end. The back-end has a RESTful API
which enables the submission or modification of data stored in
the MySQL database.
One view for each database table was built with the same name
of the respective table. Some of those views use serializers that
retrieve data from multiple tables related between themselves by
foreign keys. Whenever a query request is made, the returned
data will be returned as response (also in a JSON format).
All these pages will allow to receive requests to insert, update
or delete data entries. Besides that, all of those will contain
features to allow to filter and/or search data, besides containing
pagination methods.
Since bioinformatics packages are commonly written in
Python, those tools are integrated within this application layer,
that later will be accessed by the front-end by requests.
Clustal Omega analysis was wrapped in our application using
a Clustal console (36). This view will receive the sequences
and the additional parameters as part of the request. As result,
it performs a Clustal alignment which provides the sequence
alignment output as a text response.
To buildWeblogos, the packagesweblogo1 and logomaker (37)
are used.
The ML view allows to perform the FPep prediction for
a given sequence using models trained with the in-house
Propythia package (38). This package enables the development
of ML and deep learning models for classification of peptides.
It allows to obtain protein descriptors from their sequences
1https://weblogo.readthedocs.io/
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FIGURE 2 | Structure of the relational database, showing its entities and relationships.
such as physicochemical features, and includes methods for
data preprocessing, feature selection, dimensionality reduction,
clustering and pipelines to train, evaluate and optimize ML
and deep learning models (38). The models used in this
application were trained from a dataset generated by extracting
the physicochemical features using the Descriptor module
of Propythia from a dataset where the negative instances
are composed of protein sequences from transmembrane
domains and random sequences extracted from VFP sequences
after excluding the FPep. The group of descriptors that
the Descriptors module provide include physicochemical
features calculated from the peptide’s sequence (e.g., length,
charge, charge density, number of C, H, N, O, and S atoms
within the amino acids, molecular weight, gravy, aromacity,
isoelectric point, instability index, secondary structure, molar
extinction coefficient, flexibility, aliphatic index, Boman index
and hydrophobic index); its amino acid and pseudo-amino
acid compositions (including dipeptide and tripeptide), CTD
(Composition, Transition and Distribution) information,
Conjoint Triad and sequence order, as well additional base
class peptide features. These descriptors are obtained from
functions available in the packages PyDPI (39), Biopython
(34), modlAMP (40), and pfeature (41). Calculated features
went through a wrapper feature selection process using a
Support Vector Machine (SVM) model, which had the best
performance in this dataset. From these features, the ones that
were considered as the most relevant include tripeptide and
dipeptide composition, secondary structure, autocorrelation
and CTD descriptors. Finally, ML models were trained
with the Propythia’s train_best_model function from the
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shallow machine learning class. Those models are stored in
Pickle files2.
If a certain model is selected, the file containing that model
will be loaded and used in an instance of the Propythia’s ML
class. This ML view also requires the selection of the window
size and a size for the gap. After defining those parameters,
the predicted_window function of the Propythia is executed to
perform the likelihood prediction of the subpeptide present in
a given window to be a FPeps. Those probabilities are returned in
a JSON object by the view.
2.3. Front-End
The front-end was built using a framework called Nebular3,
which is an open-source Angular User Interface Library that
consists in a pre-built modular, customizable and configurable
Angular tool. This framework enables the creation of Angular-
based web applications and speeds up the development process of
a front-end by providing several useful user-friendly and visually
appealing web components, like tables and card formats.
2.3.1. Tables’ Pages
The information of the database is found on the “Tables & Data”
option of the front-end menu. This menu option contains a list
of links for the Taxonomy, Fusion Protein and Fusion
Peptides tables. All tables are organized in a Tree Grid format:
each data entry will correspond to a table line; upon clicking on
one row, its related data, which in this app corresponds to links
to other tables connected by foreign keys, will appear below.
2.3.2. Sequence Alignment Pages
The application’s tools can be grouped together in two categories:
sequence alignment and sequence prediction. This section will
cover the first group, while the next section handles the latter.
In the Sequence Alignment tools, a page that enables the
submission of sequences to the NCBI BLAST was added. This
page encompasses parameters that allow the selection of the type
of BLAST and the database which BLAST will run against (27).
Similarly, the HMMER page allows the selection of a sequence
and the database to perform the alignment in the EMBL-EBI
portal, showing the results in their web portal (42).
The Weblogo page contains two possible ways to build
sequence logos. The first uses the Weblogo 3 portal4 (43), in
which the page will ask a minimum of three sequences, which
must be in a FASTA format. Those sequences are submitted to
the back-end to perform a Clustal Omega alignment and from
that the web portal builds a weblogo provided in PNG or raw
data formats. The second option to generate weblogos consists in
the usage of the integrated sequence logo generator of the back-
end. The PNG output will appear in the same page, on which the
user can select the type of coloring provided by the logomaker
package, as well as the number of stacks per line; the text output
will appear in a pop-up page.
2The datasets, as well a small tutorial on how the models were trained, can




The Clustal page alignment will be run in the back-end, in a
command line. The user can select parameters such as the format
of output. Upon submitting the request, one pop-up will open
in the browser to display the alignment in the required format; a
second one can appear if the guide tree data was requested.
2.3.3. Sequence Prediction Pages
The web application contains two tools relative to sequence
prediction: epitope prediction and FPep prediction.
Regarding the epitope prediction (epitopes are binding sites
that antibody molecules can attach to) the site will access to
the IEDB portal (44) to obtain an antibody epitope prediction.
The page will send a request with the sequence, selected analysis
method and window size to the back-end that will redirect to the
IEDB API. The results will be displayed in a Smart Table format.
Both Bepipred methods’ results will appear into 2 different result
tables, the rest of them just require one (45).
Regarding ML-based prediction of the location of FPeps
within the VFP, this page allows to define a VFP target sequence,
as well as specifying which model to use, from the set of
available models trained in Propythia: Support Vector Machine,
Random Forest, Gradient Boosting, K-Nearest Neighbors, Linear
Regression, Gaussian Nave Bayes, and Artificial Neural Network
models. Finally, the user can select the window and gap sizes. The
page can display those predictions in two types of output: a table
which contains every possible peptide probability of being a FPep;
and a graphical interface that, for each amino acid, displays a
color that represents themaximumprobability of all peptides that
contain that particular character of being a FPep. Moreover, for
each amino acid, a popup box will show up, informing the user
about the position within the VFP sequence and the probability
value of belonging to a FPep. These results can be downloaded
into a text file.
3. RESULTS
There are two key components of the front-end that can require
an explanation of their elements: the tables and the tools.
Figure 3 shows the representation of the Fusion Protein
page. This image contains an example of a table component and
will be used to explain all table elements present in our web
application. The list above corresponds to the description of the
table functionalities from the left to the right and top to down:
• On the dashed green rectangle on the left (number 1), there
is the side menu of the application, where the user can access
the three main data tables, as well as the bioinformatics tools
present in the server.
• On the top right, in the black box (number 2), the user can
find the link to the global search tool; upon entering a search
term, a pop-up window will be displayed if the main pages
contain results.
• The red rectangle (number 3) contains the search methods
previously described, that will determine what is shown in
the table; the search box contains an auto-complete system
with term suggestions that is executed after the input of
3 characters.
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FIGURE 3 | Fusion protein page scheme.
FIGURE 4 | Machine learning page.
• The blue rectangle (number 4) allows to download the query
result into a CSV file.
• The orange rectangle (number 5) redirects to the back-end’s
administrator page.
• The green rectangle (number 6) is the table with results from
the query request determined by the search term and the
current page; within each line, there are links to related data
(if available).
• The yellow rectangles (numbers 7.A and 7.B) show the
selection of sequences that will be provided to the web
application tools, chosen in the checkboxes on the yellow
dashed rectangle, or through the “Select All Sequences” button;
upon choosing at least one sequence, the rectangle visible at
7.B will show up, allowing the user to delete some (in the table)
or all (in the “Clear All Sequences” option) of the selected
sequences and redirect the chosen sequences to the Tools,
accessible by the buttons on the bottom of the page.
• Some columns like the one inside the dashed gray rectangle
(number 8) will contain links to redirect to the original source
of the data; the links can be UniProt, NCBI Protein, PDB or
NCBI Taxonomy data entries.
• The purple box buttons (number 9) correspond to the
pagination methods that will also determine the content of
the table.
Figure 4 shows an example of how all tool pages are structured.
Regarding the available tools, they contain a text box to insert the
sequence(s) input, which can be auto-filled if protein sequences
were selected in the Fusion Protein page: some tools (e.g.,
the multiple alignment tools) require a minimum of 3 protein
sequences in a FASTA format; however, the most basic input of
the text box is a single protein sequence. To instruct the user
about the type of input that each tool requires, the text boxes
contain placeholders with a small description of expected input.
After the text box is filled, the user can set custom values for each
of the rest of the parameters. The results of the tools can appear in
new tabs with text results (e.g., using the Clustal or Weblogo), or
to access other web portals (e.g., BLAST or HMMER). The results
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FIGURE 5 | Example of a machine learning prediction of the fusion peptide location.
FIGURE 6 | Hits retrieved upon querying the Fusion Protein page using the search term “Retroviridae.” For the sake of simplicity only the first hits are shown.
can also appear within the same page, like in the case of ML
prediction (as shown in Figure 5 and the image result ofWeblogo
built from the back-end’s functions.
3.1. Use Case-Analysis of the Retroviridae
Conservation
To illustrate the application of ViralFP, we describe the case
of a researcher that aims to obtain a general perspective
of the conservation of the VFP of a given viral family,
such as Retroviridae, to determine which regions could be
interesting universal therapeutic targets. This can be done
by accessing the Fusion Protein page, searching the
“Retroviridae” term (Figure 6), selecting all the sequences,
and sending them to the Weblogo tool page through the
corresponding option.
The sequences sent are already in the required FASTA
format. If the user wants to obtain the graphical option of the
weblogo, he/she can select the appropriate coloring to explore
the conservation (in the case of Figure 7 the selected coloring is
based on the amino acid physical-chemical properties) and the
number of characters per line (default: 25).
After running the analysis, the output is shown below
(Figure 8). Using this representation, the regions with
high conservation can be easily located, since they
correspond to positions with larger stacks. In those, the
conserved region found around positions 15 (first line)
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FIGURE 7 | View of the weblogo page with the Retroviridae fusion protein sequences provided as input.
through 60 (third line) corresponds to the FPep, a very
conserved region.
4. DISCUSSION
This work provides a useful resource for the scientific
community working with viruses and their proteins, since
it presents a tool that can be used by any researcher
interested in obtaining several types of information
regarding VFPs.
Currently, the application implements several useful
functionalities: it provides an easy access to the MySQL
database containing VFP information through a user-
friendly web interface. The proposed bioinformatics
tools are implemented in the application, through web
interfaces. ML models capable of predicting FPeps
within the VFP sequence are also available. Finally,
a full manual curation of the database information
was performed.
Future tasks within the website will include improving
the tool by improving current features and adding
new ones, including the possibility to define more
parameters within the application’s tools, improving
the initial loading time of the website and the app’s
aesthetic appearance.
Alongside these tasks, to improve the utility of this application
for the scientific community, we will try implement tools
capable of predicting themost conserved regions within proteins,
which will allow to complement the ML output, due to
FPeps tending to be conserved regions. ML models will be
improved as new data regarding FPeps is discovered and
added to the database, allowing us to update and expand its
training dataset.
Regarding the database’s information, it is imperative to add
all the relevant new entries published after the submission
of this manuscript, hopefully by implementing methodologies
capable of performing this type of search automatically and
periodically. We are going to add methods that allow users
to insert new data, as well as update some inconsistencies
that they might find in the application. We aim to add
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FIGURE 8 | Weblogo analysis of the fusion proteins from the Retroviridae family.
information regarding receptors of VFPs, as well as each
VFP’s known cleavage sites. Finally, it is important to redo
the automated searches of known inhibitors/antibodies within
Pubmed and PDB in a way that can take into consideration the
virus’ strain.
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